Skip to content

Schrodinger SDGR Payments for finance leases

Payments for finance leases at other companies

Absci Corporation logo
Absci CorporationABSI
$0-100%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$7K0.0%

Other financials

Income statement

See full
Revenue$58.6M-1.6%
Gross profit$29.5M-5.1%
Operating income-$48.8M+4.1%
Net income-$60.0M-0.4%
EPS (diluted)-$0.81+1.2%

Balance sheet

See full
Cash & equivalents$267.7M-20.7%
Total debt$107.0M-7.9%
Total equity$313.5M-16.1%
Total assets$634.2M-14.6%

Cash flow

See full
Operating cash flow-$14.8M-110%
CapEx$2.5M+321%
Free cash flow-$17.3M-112%

Valuation

See full
Market cap$1.15B-23.7%
Enterprise value$984.71M-23.1%
P/S4.5×-2.0×

Profitability

See full
Gross margin55.3%-7.3pp
Operating margin-64.7%-12.0pp
Net margin-68.5%
FCF margin9.6%+5.1pp

Returns & leverage

See full
Return on equity-45.7%
Debt / equity0.3×0.0×
Current ratio2.7×-0.7×

Where this comes from

Reported directly by Schrodinger in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeasePrincipalPayments.

The official record: Schrodinger’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Schrodinger's payments for finance leases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Schrodinger's payments for finance leases?
Schrodinger (SDGR) reported payments for finance leases of $14K in Q1 2026.
How has Schrodinger's payments for finance leases changed year-over-year?
Schrodinger's payments for finance leases decreased by 0.0% year-over-year, from $14K to $14K.
What does payments for finance leases mean?
Principal payments on finance lease obligations, reducing the lease liability on the balance sheet.